Search

Phuong N. Huynh

Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1641, 1644
Total Applications
2195
Issued Applications
1131
Pending Applications
251
Abandoned Applications
828

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5608444 [patent_doc_number] => 20060269960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/499547 [patent_app_country] => US [patent_app_date] => 2006-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9500 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269960.pdf [firstpage_image] =>[orig_patent_app_number] => 11499547 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/499547
Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein Aug 3, 2006 Issued
Array ( [id] => 5097325 [patent_doc_number] => 20070118934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax' [patent_app_type] => utility [patent_app_number] => 11/498488 [patent_app_country] => US [patent_app_date] => 2006-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 99 [patent_figures_cnt] => 99 [patent_no_of_words] => 40611 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11498488 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/498488
Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax Aug 1, 2006 Abandoned
Array ( [id] => 6639723 [patent_doc_number] => 20100036095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Human CD59 mutants with modulated complement binding activity' [patent_app_type] => utility [patent_app_number] => 11/997650 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24800 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20100036095.pdf [firstpage_image] =>[orig_patent_app_number] => 11997650 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/997650
Human CD59 mutants with modulated complement binding activity Jul 31, 2006 Abandoned
Array ( [id] => 8629392 [patent_doc_number] => 08361461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Anti-IGF-IR antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/989204 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 18 [patent_no_of_words] => 19544 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11989204 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/989204
Anti-IGF-IR antibodies and uses thereof Jul 20, 2006 Issued
Array ( [id] => 5074814 [patent_doc_number] => 20070014789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Humanized antibody conjugates and related methods, assays, reagents, and kits' [patent_app_type] => utility [patent_app_number] => 11/457537 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7714 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014789.pdf [firstpage_image] =>[orig_patent_app_number] => 11457537 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/457537
Humanized antibody conjugates and related methods, assays, reagents, and kits Jul 13, 2006 Abandoned
Array ( [id] => 5834238 [patent_doc_number] => 20060246068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Polypeptides having a triggering NK activity and biological applications' [patent_app_type] => utility [patent_app_number] => 11/483991 [patent_app_country] => US [patent_app_date] => 2006-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8051 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246068.pdf [firstpage_image] =>[orig_patent_app_number] => 11483991 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/483991
Polypeptides having a triggering NK activity and biological applications Jul 9, 2006 Issued
Array ( [id] => 5331497 [patent_doc_number] => 20090111974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Treatment of Liver Cirrhosis and Its Complications' [patent_app_type] => utility [patent_app_number] => 11/922702 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5142 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111974.pdf [firstpage_image] =>[orig_patent_app_number] => 11922702 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/922702
Treatment of liver cirrhosis and its complications Jun 29, 2006 Issued
Array ( [id] => 4982384 [patent_doc_number] => 20070086942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Methods and compositions for generating bioactive assemblies of increased complexity and uses' [patent_app_type] => utility [patent_app_number] => 11/478021 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19208 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20070086942.pdf [firstpage_image] =>[orig_patent_app_number] => 11478021 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/478021
Methods and compositions for generating bioactive assemblies of increased complexity and uses Jun 28, 2006 Issued
Array ( [id] => 4733401 [patent_doc_number] => 20080050380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Glycoprotein VI and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/478074 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 72343 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050380.pdf [firstpage_image] =>[orig_patent_app_number] => 11478074 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/478074
Glycoprotein VI and uses thereof Jun 28, 2006 Issued
Array ( [id] => 204335 [patent_doc_number] => 07629145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'VEGF-related protein' [patent_app_type] => utility [patent_app_number] => 11/427463 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 25893 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629145.pdf [firstpage_image] =>[orig_patent_app_number] => 11427463 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/427463
VEGF-related protein Jun 28, 2006 Issued
Array ( [id] => 5851122 [patent_doc_number] => 20060234313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Modulation of angiogenesis through targeting of arginyl transferase (ATE1)' [patent_app_type] => utility [patent_app_number] => 11/473568 [patent_app_country] => US [patent_app_date] => 2006-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7841 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234313.pdf [firstpage_image] =>[orig_patent_app_number] => 11473568 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/473568
Modulation of angiogenesis through targeting of arginyl transferase (ATE1) Jun 21, 2006 Issued
Array ( [id] => 6635951 [patent_doc_number] => 20100226924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION' [patent_app_type] => utility [patent_app_number] => 11/917907 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 7654 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226924.pdf [firstpage_image] =>[orig_patent_app_number] => 11917907 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/917907
Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection Jun 19, 2006 Issued
Array ( [id] => 4932444 [patent_doc_number] => 20080003219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'DELIVERY OF AN OCULAR AGENT' [patent_app_type] => utility [patent_app_number] => 11/425194 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8385 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20080003219.pdf [firstpage_image] =>[orig_patent_app_number] => 11425194 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/425194
DELIVERY OF AN OCULAR AGENT Jun 19, 2006 Abandoned
Array ( [id] => 5699607 [patent_doc_number] => 20060216291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Glycoprotein VI and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/447460 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 52667 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216291.pdf [firstpage_image] =>[orig_patent_app_number] => 11447460 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/447460
Glycoprotein VI and uses thereof Jun 5, 2006 Abandoned
Array ( [id] => 5921444 [patent_doc_number] => 20060240036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis' [patent_app_type] => utility [patent_app_number] => 11/445311 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22695 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240036.pdf [firstpage_image] =>[orig_patent_app_number] => 11445311 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/445311
I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis Jun 1, 2006 Abandoned
Array ( [id] => 5360458 [patent_doc_number] => 20090035252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Method of inducing a CTL response' [patent_app_type] => utility [patent_app_number] => 11/418497 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26495 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035252.pdf [firstpage_image] =>[orig_patent_app_number] => 11418497 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/418497
Method of inducing a CTL response May 2, 2006 Abandoned
Array ( [id] => 8652649 [patent_doc_number] => 08372393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Method of inducing a CTL response' [patent_app_type] => utility [patent_app_number] => 11/418397 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 26604 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11418397 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/418397
Method of inducing a CTL response May 2, 2006 Issued
Array ( [id] => 5514256 [patent_doc_number] => 20090214562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection' [patent_app_type] => utility [patent_app_number] => 11/919927 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21380 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214562.pdf [firstpage_image] =>[orig_patent_app_number] => 11919927 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/919927
Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection May 1, 2006 Abandoned
Array ( [id] => 5141364 [patent_doc_number] => 20070003580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound' [patent_app_type] => utility [patent_app_number] => 11/413489 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11616 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003580.pdf [firstpage_image] =>[orig_patent_app_number] => 11413489 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/413489
Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound Apr 27, 2006 Issued
Array ( [id] => 5224694 [patent_doc_number] => 20070253960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Pharmaceutical removal of vascular extensions from a degenerating disc' [patent_app_type] => utility [patent_app_number] => 11/413346 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10566 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253960.pdf [firstpage_image] =>[orig_patent_app_number] => 11413346 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/413346
Pharmaceutical removal of vascular extensions from a degenerating disc Apr 27, 2006 Abandoned
Menu